Journal article
VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats
Abstract
Idiopathic pulmonary fibrosis (IPF) can lead to the development of secondary pulmonary hypertension (PH) and ultimately death. Despite this known association, the precise mechanism of disease remains unknown. Using a rat model of IPF, we explored the role of the proangiogenic and antiapoptotic growth factor VEGF in the vascular remodeling that underlies PH. In this model, adenoviral delivery of active TGF-beta1 induces pulmonary arterial …
Authors
Farkas L; Farkas D; Ask K; Möller A; Gauldie J; Margetts P; Inman M; Kolb M
Journal
Journal of Clinical Investigation, Vol. 119, No. 5, pp. 1298–1311
Publisher
American Society for Clinical Investigation
Publication Date
May 1, 2009
DOI
10.1172/jci36136
ISSN
0021-9738
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AnimalsApoptosisBronchoalveolar Lavage FluidCaspase 3Disease Models, AnimalEndothelial CellsEye ProteinsFemaleFibroblastsGene ExpressionGenetic TherapyHumansHypertension, PulmonaryIdiopathic Pulmonary FibrosisLungMicrovesselsModels, BiologicalNerve Growth FactorsNitric Oxide Synthase Type IIIPhosphorylationPulmonary ArteryRatsRats, Sprague-DawleySerpinsSerum AlbuminSmad2 ProteinTransforming Growth Factor beta1Vascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2